Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FY8BA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $154,610
Award facts
- Contract value 100% obligated
- $154,610.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $154,610.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens. The contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a competitive award with no set-aside designation. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for pharmaceutical supply to military healthcare systems worldwide.
Cosentyx is a biologic immunosuppressant used to treat inflammatory conditions including psoriasis, psoriatic arthritis, ankylosing spondylitis, and other autoimmune disorders, making it a critical pharmaceutical asset for military medical support. AmerisourceBergen, as a major pharmaceutical distributor and federal healthcare vendor, maintains extensive capability to fulfill specialized medical procurement requirements across multiple therapeutic domains. This delivery order exemplifies the company's ongoing role in supporting Defense Health Agency operations and other federal healthcare systems through the DLA's comprehensive pharmaceutical prime vendor platform.
Quick answers
Who was awarded contract SPE2DB25FY8BA?
SPE2DB25FY8BA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FY8BA worth?
The government has obligated $154,610 on SPE2DB25FY8BA.
Is contract SPE2DB25FY8BA an order under another contract?
Yes. SPE2DB25FY8BA is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8BA competed?
The extent of competition for SPE2DB25FY8BA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award